HBV Serum DNA and RNA Levels in Nucleos(t)ide Analogue-Treated or Untreated Patients During Chronic and Acute Infection

Hepatology - United States
doi 10.1002/hep.30082
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

HBV RNA Virion-Like Particles Produced Under Nucleos(t)ide Analogues Treatment Are Mainly Replication-Deficient

Journal of Hepatology
Hepatology
2018English

Potential Resistant Mutations Within HBV Reverse Transcriptase Sequences in Nucleos(t)ide Analogues-Experienced Patients With Hepatitis B Virus Infection

Scientific Reports
Multidisciplinary
2019English

Tenofovir Plus Entecavir Combination Therapy for Chronic Hepatitis B With Nucleos(t)ide Analogue Failure

The European Research Journal
2020English

Off-Treatment Efficacy of 3-Year Nucleos(t)ide Analogues in Chronic Hepatitis B Patients

Kaohsiung Journal of Medical Sciences
Medicine
2016English

Combination Nucleos(t)ide Analogue as Initial Treatment for Chronic Hepatitis B: Have We Put This to Rest?

Hepatology
MedicineHepatology
2013English

Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B—A Nationwide Cohort Study

Gastroenterology
HepatologyGastroenterology
2014English

Editorial: HBeAg Seroconversion Is Not Sufficient to Allow Cessation of Nucleos(t)ide Analogue Treatment in Caucasian Hepatitis B Patients

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Treatment of HBeAg-Negative Chronic Hepatitis B Patients With Nucleos(t)ide Analogues in Burkina Faso

Open Journal of Gastroenterology
2016English

Impact of Antiviral Therapy With Nucleos(t)ide Analog on Survival of Patients With HBV-related Small Hepatocellular Carcinomas

Cancer Management and Research
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy